Integrated Filing — IndAS


General information about company

Scrip Code 524394
NSE Symbol VIMTALABS
MSEI Symbol NOTLISTED
ISIN INE579C01029
Name of company Vimta Labs Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Contract Research and Testing Services
Start date and time of board meeting 28-Apr-2025   10:30:00
End date and time of board meeting 28-Apr-2025   15:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-24
Indicate Company website link for updated RPT policy of the Company https://vimta.com/wp-content/uploads/4.Related-Party-Transaction-Policy-V2.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable.



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 944410000 3439820000
Other income 16400000 42400000
Total income 960810000 3482220000
2 Expenses
(a) Cost of materials consumed 181770000 714470000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 272640000 970180000
(e) Finance costs 4380000 19000000
(f) Depreciation, depletion and amortisation expense 92120000 352890000
(f) Other Expenses
1 Other Expenses 159630000 535680000
Total other expenses 159630000 535680000
Total expenses 710540000 2592220000
3 Total profit before exceptional items and tax 250270000 890000000
4 Exceptional items 0 0
5 Total profit before tax 250270000 890000000
6 Tax expense
7 Current tax 69660000 209790000
8 Deferred tax -2580000 12660000
9 Total tax expenses 67080000 222450000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 183190000 667550000
12 Profit (loss) from discontinued operations before tax 0 14050000
13 Tax expense of discontinued operations 0 8180000
14 Net profit (loss) from discontinued operation after tax 0 5870000
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 183190000 673420000
17 Other comprehensive income net of taxes -190000 -370000
18 Total Comprehensive Income for the period 183000000 673050000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 44470000 44470000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 3744010000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 8.22 30.02
Diluted earnings (loss) per share from continuing operations 8.08 29.6
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0.26
Diluted earnings (loss) per share from discontinued operations 0 0.26
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.22 30.28
Diluted earnings (loss) per share from continuing and discontinued operations 8.08 29.86
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Due to word restriction, we are unable to include the detailed note. Kindly refer to the PDF file uploaded on the Stock Exchange website as well as the company's website for the complete notes.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2235690000
Capital work-in-progress 380970000
Investment property 0
Goodwill 0
Other intangible assets 64190000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 24240000
Total non-current financial assets 24240000
Deferred tax assets (net) 61610000
Other non-current assets 20460000
Total non-current assets 2787160000
2 Current assets
Inventories 250560000
Current financial asset
Current investments 0
Trade receivables, current 1062430000
Cash and cash equivalents 158360000
Bank balance other than cash and cash equivalents 171070000
Loans, current 810000
Other current financial assets 17850000
Total current financial assets 1410520000
Current tax assets (net)
Other current assets 217080000
Total current assets 1878160000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 4665320000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 44470000
Other equity 3744010000
Total equity attributable to owners of parent 3788480000
Non controlling interest
Total equity 3788480000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 32240000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities
Total non-current financial liabilities 32240000
Provisions, non-current 118760000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 82170000
Total non-current liabilities 233170000
Current liabilities
Current financial liabilities
Borrowings, current 52910000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 38890000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 66040000
Total Trade payable 104930000
Other current financial liabilities 331420000
Total current financial liabilities 489260000
Other current liabilities 121710000
Provisions, current 32700000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 643670000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 876840000
Total equity and liabilites 4665320000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement of net defined benefit liability -260000 -500000
Total Amount of items that will not be reclassified to profit and loss -260000 -500000
2 Income tax relating to items that will not be reclassified to profit or loss -70000 -130000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -190000 -370000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 890000000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories -3660000
Adjustments for decrease (increase) in trade receivables, current -218010000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -30140000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 1750000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 17180000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 80830000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 357330000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -1200000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 73350000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -1470000
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 18500000
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 14050000
Other adjustments for non-cash items -20350000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 288160000
Net cash flows from (used in) operations 1178160000
Dividends received 0
Interest paid -15850000
Interest received -15690000
Income taxes paid (refund) 220150000
Other inflows (outflows) of cash -12040000
Net cash flows from (used in) operating activities 946130000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 45150000
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 790640000
Proceeds from sales of investment property 28740000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 4300000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 13270000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -47590000
Net cash flows from (used in) investing activities -755370000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 130000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 7240000
Repayments of borrowings 116500000
Payments of lease liabilities 0
Dividends paid 44340000
Interest paid 13340000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -166810000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 23950000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 23950000
Cash and cash equivalents cash flow statement at beginning of period 134410000
Cash and cash equivalents cash flow statement at end of period 158360000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s Gattamaneni & Co Yes 31-Mar-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Vimta Labs Limited Dr. S P Vasireddi Executive Chairman Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration to executive directors have been approved by Shareholders too. 20160000 0 770000
2 Vimta Labs Limited Harriman Vungal Executive Director (ED) - Operations Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration to executive directors have been approved by Shareholders too. 13440000 0 530000
3 Vimta Labs Limited Harita Vasireddi Managing Director Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration to executive directors have been approved by Shareholders too. 13440000 0 530000
4 Vimta Labs Limited Satya Sreenivas Neerukonda Executive Director Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration to executive directors have been approved by Shareholders too. 13440000 0 530000
5 Vimta Labs Limited Dr. S P Vasireddi Executive Chairman Any other transaction Commission All the Related Parties Transaction are been approved by the Audit committee and the remuneration (including commission) to executive directors have been approved by Shareholders too. 3600000 0 1460000
6 Vimta Labs Limited Harriman Vungal Executive Director (ED) - Operations Any other transaction Commission All the Related Parties Transaction are been approved by the Audit committee and the remuneration (including commission) to executive directors have been approved by Shareholders too. 3600000 0 1540000
7 Vimta Labs Limited Harita Vasireddi Managing Director Any other transaction Commission All the Related Parties Transaction are been approved by the Audit committee and the remuneration (including commission) to executive directors have been approved by Shareholders too. 2400000 0 2310000
8 Vimta Labs Limited Satya Sreenivas Neerukonda Executive Director Any other transaction Commission All the Related Parties Transaction are been approved by the Audit committee and the remuneration (including commission) to executive directors have been approved by Shareholders too. 2400000 0 2310000
9 Vimta Labs Limited Sireesh Chandra Vungal Son of ED - Operations Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration paid to RP have been approved by Shareholders too. 7530000 -200000 140000
10 Vimta Labs Limited Praveena Vasireddi Daughter of Chairman Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration paid to RP have been approved by Shareholders too. 4180000 10000 310000
11 Vimta Labs Limited Sujani Vasireddi Company Secretary Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration paid to RP have been approved by Shareholders too. 4510000 0 200000
12 Vimta Labs Limited D R Narahai Naidu Chief Financial Officer Remuneration He was acting as CFO, and was not related to any person from Promoter or Promoter group. His remuneration was approved approved in the Audit Committee and Board dated 22.01.2021. His last working day was 10.12.2024. 6840000 0 0
13 Vimta Labs Limited Siva Rama Krishna Kambhampati Chief Financial Officer Remuneration Shiva Rama Krishna Kambhampati is appointed as CFO w.e.f., 06th March,2025. The Audit Committee and Board has approved his appointment term along with remuneration in the meeting held on 24.01.2025 360000 0 360000
14 Vimta Labs Limited Sudheshna Vungal Daughter of ED - Operations Remuneration All the Related Parties Transaction are been approved by the Audit committee and the remuneration paid to RP have been approved by Shareholders too. 3520000 0 180000
15 Vimta Labs Limited Harriman Vungal Executive Director (ED) - Operations Any other transaction Rent The value of the transaction is Zero. 0 0 0
16 Vimta Labs Limited Y Prameela Rani Independent Director Any other transaction Sitting fee paid to the directors Sitting fee paid to the directors 230000 0 0
17 Vimta Labs Limited Sanjay Dave Independent Director Any other transaction Sitting fee paid to the directors Sitting fee paid to the directors 260000 0 0
18 Vimta Labs Limited G Purnachandra Rao Independent Director Any other transaction Sitting fee paid to the directors Sitting fee paid to the directors 260000 0 0
19 Vimta Labs Limited Bloomedha Info Solutions Private Limited Companies in which some of the Directors or other relatives are interested Purchase of goods or services The related party transaction is approved by Audit Committee. 420000 940000 0
20 Vimta Labs Limited Eurofins Analytical Services India Pvt Ltd Entity holding 10% or more Equity Shares Purchase of goods or services The related party transaction is approved by Audit Committee. 3360000 0 0
21 Vimta Labs Limited Eurofins DiscoverX Products, LLC Entity holding 10% or more Equity Shares Purchase of goods or services The related party transaction is approved by Audit Committee. 27610000 0 6240000
22 Vimta Labs Limited Escientia Biopharma Private Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 110000 -60000 0
23 Vimta Labs Limited Escientia Advanced Sciences Private Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 4850000 -2220000 -970000
24 Vimta Labs Limited Avanti Frozen Foods Private Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 0 -80000 -40000
25 Vimta Labs Limited Krishna Institute of Medical Sciences Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 0 -40000 0
26 Vimta Labs Limited Emtac Laboratories Private Limited Wholly Owned Subsidiary Sale of goods or services The related party transaction is approved by Audit Committee.However, EMTAC got merged with VIMTA during this FY. 40590000 -4530000 0
27 Vimta Labs Limited Avantel Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 3370000 0 -20000
28 Vimta Labs Limited Avanti Feeds Limited Companies in which some of the Directors or other relatives are interested Sale of goods or services The related party transaction is approved by Audit Committee. 400000 0 0
Total value of transaction during the reporting period 180880000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt